Wednesday, November 18, 2009

Boehringer Ingelheim Working on "Female Viagra?"

It seems that we may have a so-called female Viagra on the market in the next few years if Boehringer Ingelheim is able to get FDA approval for a drug called flibanserin.

With up to a quarter of women suffering from low libido, it is predicted to be at least as successful as Viagra, with worldwide sales topping £2billion a year.

Like Viagra, which was originally designed to treat heart problems, flibanserin was formulated with another purpose in mind.

It was created as an anti-depressant but those taking part in trials said it did nothing to boost their mood but did wonders for their sex drive.

No comments: